Catalogo dei prodotti della ricerca

SCUDERI, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.045
EU - Europa 1.366
AS - Asia 824
AF - Africa 127
SA - Sud America 64
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.000
IT - Italia 776
SG - Singapore 339
IN - India 229
CN - Cina 175
SE - Svezia 124
RU - Federazione Russa 94
FI - Finlandia 88
DE - Germania 77
UA - Ucraina 73
TG - Togo 69
NG - Nigeria 43
AR - Argentina 37
CA - Canada 36
GB - Regno Unito 29
BR - Brasile 27
BG - Bulgaria 20
ID - Indonesia 18
IE - Irlanda 18
FR - Francia 17
IL - Israele 16
JP - Giappone 15
NL - Olanda 15
HK - Hong Kong 11
MX - Messico 9
BE - Belgio 8
TR - Turchia 8
AU - Australia 6
AT - Austria 5
IR - Iran 5
EG - Egitto 4
ES - Italia 4
TN - Tunisia 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
MA - Marocco 3
PL - Polonia 3
PT - Portogallo 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
ZA - Sudafrica 3
DK - Danimarca 2
KR - Corea 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
DZ - Algeria 1
GR - Grecia 1
MY - Malesia 1
PH - Filippine 1
PK - Pakistan 1
VN - Vietnam 1
Totale 5.437
Salva come PNG Salva come JPEG
Città #
Rome 429
Fairfield 419
Chandler 326
Singapore 265
Ashburn 200
Houston 174
Wilmington 165
Seattle 158
Woodbridge 157
Cambridge 123
Princeton 113
Beijing 95
Santa Clara 95
Ann Arbor 93
Plano 84
Lomé 69
Millbury 61
San Paolo di Civitate 51
Boston 50
Stockholm 49
Dearborn 48
Lawrence 36
Federal 35
Helsinki 33
Andover 32
San Diego 30
Grafing 24
Moscow 24
Boardman 21
Falkenstein 20
Norwalk 20
San Mateo 20
Sofia 20
Toronto 20
Dublin 18
Jacksonville 18
Jakarta 18
Milan 16
Los Angeles 13
Surat 13
Tel Aviv 11
Des Moines 9
Nuremberg 9
Bologna 8
Brussels 8
Falls Church 8
Sacramento 8
Guidonia Montecelio 7
Nanjing 7
New York 7
Palermo 7
Yubileyny 7
Buffalo 6
Bühl 6
Council Bluffs 6
Culiacán 6
Halifax 6
Tampa 6
Catania 5
Hefei 5
Kunming 5
Livorno 5
Mannheim 5
Niterói 5
Pune 5
San Jose 5
San Nicola la Strada 5
Van 5
Viterbo 5
Bari 4
Birmingham 4
Florence 4
Genoa 4
Guangzhou 4
Indiana 4
Kai Yi Wan 4
La Spezia 4
Lucknow 4
Newton Upper Falls 4
Ottawa 4
Paradise 4
Paris 4
Pescara 4
Phoenix 4
Saint-cyprien 4
Stuttgart 4
Washington 4
Amsterdam 3
Aprilia 3
Brescia 3
Bussi sul Tirino 3
Changsha 3
Fossano 3
Grottaglie 3
Hyderabad 3
Kurosunadai 3
Laurel 3
London 3
Manchester 3
Nanchang 3
Totale 3.953
Salva come PNG Salva come JPEG
Nome #
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 118
Astrocyte Function Is Affected by Aging and Not Alzheimer’s Disease: A Preliminary Investigation in Hippocampi of 3xTg-AD Mice 110
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 108
null 99
Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for binge eating disorder 98
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system 94
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease 90
Palmitoylethanolamide regulates production of pro-angiogenic mediators in a model of β amyloid-induced astrogliosis in vitro. 88
Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes 88
Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptide 88
Cannabidiol in Medicine: A Review of its Therapeutic Potential in CNS Disorders 86
Resilient and vulnerable rats to acute foot shock stress show different glial cell responses: possible rescue of pathological alterations by a single ketamine administration 85
Altered brain cholesterol/isoprenoid metabolism in a rat model of autism spectrum disorders 85
Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer’s disease: in vitro and in vivo evidence 82
Astrocyte: an innovative approach for Alzheimer's disease therapy 82
Opposing control of cannabinoid receptor stimulation on amyloid-{beta} induced reactive gliosis: in vitro and in vivo evidence. 82
Neuroglia in the autistic brain: evidence from a preclinical model 81
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes 80
Altered waste disposal system in aging and Alzheimer’s disease: focus on astrocytic aquaporin-4 78
Post-COVID-19 neuropsychiatric syndrome. Is maladaptive glial recovery to blame? 78
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α 77
Sorafenib chemosensitization by caryophyllane sesquiterpenes in liver, biliary, and pancreatic cancer cells: the role of STAT3/ABC transporter axis 76
S100B and APP promote a gliocentric shift and impaired neurogenesis in down syndrome neural progenitors 73
S100B-p53 disengagement by pentamidine promotes apoptosis and inhibits cellular migration via aquaporin-4 and metalloproteinase-2 inhibition in C6 glioma cells 73
How useful are biomarkers for the diagnosis of Alzheimer’s disease and especially for its therapy? 72
Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders? 71
S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells. 67
The antiprotozoal drug pentamidine ameliorates experimentally induced acute colitis in mice 67
Role of astrocytes in major neurological disorders: The evidence and implications 66
Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression. 65
Cannabidiol Reduces Intestinal Inflammation through the Control of Neuroimmune Axis 64
CB1 receptor selective activation inhibits β-amyloid-induced Inos protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons 63
Cannabidiol: A Promising Drug for Neurodegenerative Disorders ? 63
How could retinoids fit into Alzheimer's therapy? 63
Editorial: Neuroglia Molecular Mechanisms in Psychiatric Disorders 61
Are Retinoids a Promise for Alzheimer's Disease Management? 58
An animal model of Alzheimer disease based on the intrahippocampal injection of amyloid beta-peptide (Abeta) 58
Cannabinoid CB(1) receptor stimulation affords neuroprotection in MPTP-induced neurotoxicity by attenuating S100B up-regulation in vitro. 57
Differential Cannabinoid Receptor Expression during Reactive Gliosis: a Possible Implication for a Nonpsychotropic Neuroprotection 57
Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement 56
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 55
Acute Ketamine Facilitates Fear Memory Extinction in a Rat Model of PTSD Along With Restoring Glutamatergic Alterations and Dendritic Atrophy in the Prefrontal Cortex 55
Sirtuin modulators control reactive gliosis in an in vitro model of alzheimer's disease 52
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer's Disease 52
Investigating the role of oligodendrocytes in a pharmacological model of autism spectrum disorders 52
Neuroinflammation in Alzheimer's disease: friend or foe? 52
Cannabidiol in vivo suppresses Aβ-induced reactive gliosis. 51
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview 51
null 47
S100B protein promoted tau protein hyperphosphorilation through DKK-1 protein up-regulation and relative Wnt pathway disruption in cultured human neurons. 46
Preparation of rat hippocampal organotypic cultures and application to study amyloid beta-peptide toxicity 45
Ultramicronized palmitoylethanolamide improves learning and memory in a triple transgenic mouse model of Alzheimer's disease through a combination of anti-inflammatory and neuroprotective effects 45
Possibile ruolo delle ALIAmidi nelle patologie degenerative del sistema nervoso. 44
Targeting neuroinflammation in Alzheimer’s disease 44
Cannabidiol inhibits beta amyloid-induced reactive gliosis through peroxisome proliferator-activated receptor-gamma involvement. 44
The role of neuroglia in autism spectrum disorders 43
The Impact of Complex PTSD on Suicide Risk in Patients with Bipolar Disorder: A Cross-Sectional Study 41
Genomic and functional profiling of human Down syndrome neural progenitor implicates S100B and Aquaporin 4 in cell injury 41
Astrocyte-neuron interplay in Alzheimer's disease: evidence from an innovative and promising pharmacological manipulation in a triple transgenic model of the disease 41
Targeting the oxytocinergic system. A possible pharmacological strategy for the treatment of inflammation occurring in different chronic diseases 41
Reactive astrogliosis and neuronal impairment: in vitro and in vivo evidence on palmitoylethanolamide effects in a triple transgenic model of Alzheimer’s disease 40
Cannabidiol inhibits beta amyloid-induced reactive gliosis through peroxisome proliferator-activated receptor-gamma involvement. 40
The protective effects of ultramicronized palmitoylethanolamide on the glutamatergic system in a triple transgene mouse model of Alzheimer disease. 39
Successful and unsuccessful brain aging in pets: Pathophysiological mechanisms behind clinical signs and potential benefits from palmitoylethanolamide nutritional intervention 39
Palmitoylethanolamide counteracts reactive gliosis in an in vivo model of Alzheimer’s disease 38
PPARγ mediates cannabidiol antiinflammatory and neuroprotective effects in an in vitro model of Alzheimer’s disease. 38
Glia and Alzheimer’s disease: the pharmacological manipulation as promising tool against pathology progression 38
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 38
Anti-inflammatory/neuroprotective properties of palmitoylethanolamide in a model of beta amyloid neurotoxicity. 37
Cannabidiol controls intestinal inflammation through the modulation of enteric glial cell activation. 36
Antinflammatory/neuroprotective properties of palmitoylethanolamide in a model of Alzheimer’s disease 36
Palmitoylethanolamide is able to attenuate astrocyte activation and neuroinflammation in models of Alzheimer’s desease 36
Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD 35
Cannabinoids and PPARs: new tools for Alzheimer’s disease treatment. 35
Neuroprotective effects of palmitoylethanolamide in Alzheimer’s disease 35
Sirtuins blunt reactive gliosis in an in vitro model of Alzheimer’s disease. 35
Neuroglia in psychiatric disorders 35
Astroglial serotonin receptors as the central target of classic antidepressants 34
Palmitoylethanolamide counteracts reactive astrogliosis in in vitro models of Alzheimer’s disease 33
The Importance of the Enteric Glia and its Related Product S100b Protein in Gut Inflammation 32
Palmitoylethanolamide exerts neuroprotective effects in an in vivo model of Alzheimer’s disease 32
Quale futuro per la terapia delle malattie neurodegenerative:nuove evidenze dalla ricerca preclinica. 32
Effect of palmytoilethanolamide in 3xTg-AD astrocytes as in vitro model of Alzheimer’s disease 32
Proprietà antinfiammatorie della PEA in cellule C6 stimolate con il peptide beta amiloide 31
Prenatal ethanol exposure affects endocannabinoids levels in prefrontal cortex of adult rat offspring 31
Astrocytes. The housekeepers and guardians of the CNS 31
Palmitoylethanolamide blunts beta amyloid-induced reactive astrogliosis. 30
Astrocytes and Alzheimer’s disease: the pharmacological manipulation as promising tool against pathology progression. Evidence from a triple transgenic model of the disease 30
Principles of astrogliopathology 30
Effect of ultramicronized-palmytoilethanolamide on astrocyte dysfunction in a triple transgenic model of Alzheimer’s disease 29
Astrocytes in psychiatric disorders 29
Dual control by cannabinoid CB1 and CB2 receptors of S100B protein expression and glial cell proliferation following administration of beta amyloid in vitro and in vivo. 28
De Filippis D., Esposito G, Savani C, Scuderi C, D’Amico A, Di Marzo V, Steardo L, Teresa Iuvone. 28
Effect of palmitoylethanolamide in a triple transgenic model of Alzheimer’s disease 27
Effects of palmitoylethanolamide on the onset and progression of the pathology on a triple transgene mouse model of Alzheimer disease. 27
Opposing control of cannabinoid receptor stimulation on amyloid-β induced reactive gliosis: in vitro and in vivo evidence. 27
null 26
Unraveling the Complexity: Exploring the Intersection of Panic Disorder, Dissociation, and Complex Post-Traumatic Stress Disorder 26
Palmitoylethanolamide controls astrocyte activation and the amyloidogenic pathway in an in vivo model of Alzheimer’s disease 26
Hippocampal metabolic and behavioural improvements after palmitoylethanolamide treatment at early stage of development in a triple transgene mouse model of Alzheimer disease. 26
Totale 5.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.552
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020347 0 0 0 0 0 0 0 85 88 85 55 34
2020/2021370 30 34 9 25 12 4 8 31 59 64 41 53
2021/20221.073 23 51 86 11 116 95 18 118 100 86 161 208
2022/20231.103 226 217 54 76 151 107 12 52 130 21 38 19
2023/2024599 32 92 19 53 48 49 29 65 7 70 57 78
2024/2025902 119 83 80 104 137 182 156 41 0 0 0 0
Totale 5.690